Literature DB >> 11377714

Sensitive and reproducible quantitation of mucosal HIV-1 RNA and DNA viral burden in patients with detectable and undetectable plasma viral HIV-1 RNA using endoscopic biopsies.

P A Anton1, M A Poles, J Elliott, S H Mao, I McGowan, H J Lenz, I S Chen.   

Abstract

Mucosal tissue is the main portal of entry for HIV-1 infection and, in macaques, has been demonstrated to be a significant compartment for viral replication and CD4+ T lymphocyte depletion. Quantitating tissue viral burden in addition to plasma viral load provides insights into HIV-1 pathogenesis and an additional means to gauge antiretroviral response. The aim of this study was to develop reliable, reproducible, and sensitive assays to quantitate tissue viral burden of HIV-1 RNA and DNA using 1-3 endoscopically acquired, rectosigmoid biopsies. Total DNA and RNA were simultaneously extracted following homogenization from the same tissue samples. Quantitative polymerase chain reaction (PCR) assay in the HIV-1 LTR region was used to detect viral DNA and RT-PCR for viral RNA. It was determined that HIV-1 RNA and DNA can be reproducibly quantified from a single rectosigmoid biopsy with minimal intra-assay or intra-patient variability. These results reflect high recovery of extracted nucleic acids with calculated results accurately reflecting in vivo levels. The techniques outlined differ from currently available approaches by incorporating control standards to identify loss or degradation of RNA and DNA from acquisition through the in vitro assay and permit extraction with high yields of RNA and DNA from the same tissue sample.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11377714     DOI: 10.1016/s0166-0934(01)00295-6

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  10 in total

1.  Immunodominant HIV-specific CD8+ T-cell responses are common to blood and gastrointestinal mucosa, and Gag-specific responses dominate in rectal mucosa of HIV controllers.

Authors:  April L Ferre; Donna Lemongello; Peter W Hunt; Megan M Morris; Juan Carlos Garcia; Richard B Pollard; Hal F Yee; Jeffrey N Martin; Steven G Deeks; Barbara L Shacklett
Journal:  J Virol       Date:  2010-07-28       Impact factor: 5.103

Review 2.  Total HIV-1 DNA, a Marker of Viral Reservoir Dynamics with Clinical Implications.

Authors:  Véronique Avettand-Fènoël; Laurent Hocqueloux; Jade Ghosn; Antoine Cheret; Pierre Frange; Adeline Melard; Jean-Paul Viard; Christine Rouzioux
Journal:  Clin Microbiol Rev       Date:  2016-10       Impact factor: 26.132

3.  Binding and transfer of human immunodeficiency virus by DC-SIGN+ cells in human rectal mucosa.

Authors:  Kevin B Gurney; Julie Elliott; Hoorig Nassanian; Carol Song; Elizabeth Soilleux; Ian McGowan; Peter A Anton; Benhur Lee
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

4.  Differences in HIV burden and immune activation within the gut of HIV-positive patients receiving suppressive antiretroviral therapy.

Authors:  Steven A Yukl; Sara Gianella; Elizabeth Sinclair; Lorrie Epling; Qingsheng Li; Lijie Duan; Alex L M Choi; Valerie Girling; Terence Ho; Peilin Li; Katsuya Fujimoto; Harry Lampiris; C Bradley Hare; Mark Pandori; Ashley T Haase; Huldrych F Günthard; Marek Fischer; Amandeep K Shergill; Kenneth McQuaid; Diane V Havlir; Joseph K Wong
Journal:  J Infect Dis       Date:  2010-10-12       Impact factor: 5.226

5.  Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy.

Authors:  Steven A Yukl; Amandeep K Shergill; Kenneth McQuaid; Sara Gianella; Harry Lampiris; C Bradley Hare; Mark Pandori; Elizabeth Sinclair; Huldrych F Günthard; Marek Fischer; Joseph K Wong; Diane V Havlir
Journal:  AIDS       Date:  2010-10-23       Impact factor: 4.177

6.  Differential immunogenicity of vaccinia and HIV-1 components of a human recombinant vaccine in mucosal and blood compartments.

Authors:  Peter A Anton; F Javier Ibarrondo; W John Boscardin; Ying Zhou; Elissa J Schwartz; Hwee L Ng; Mary Ann Hausner; Roger Shih; Julie Elliott; Patricia M Hultin; Lance E Hultin; Charles Price; Marie Fuerst; Amy Adler; Johnson T Wong; Otto O Yang; Beth D Jamieson
Journal:  Vaccine       Date:  2008-06-17       Impact factor: 3.641

7.  Cytokine expression in the colonic mucosa of human immunodeficiency virus-infected individuals before and during 9 months of antiretroviral therapy.

Authors:  Hubert Schulbin; Hagen Bode; Hartmut Stocker; Wolfgang Schmidt; Thomas Zippel; Christoph Loddenkemper; Elisabeth Engelmann; Hans-Jörg Epple; Keikawus Arastéh; Martin Zeitz; Reiner Ullrich
Journal:  Antimicrob Agents Chemother       Date:  2008-06-23       Impact factor: 5.191

8.  Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control.

Authors:  April L Ferre; Peter W Hunt; J William Critchfield; Delandy H Young; Megan M Morris; Juan C Garcia; Richard B Pollard; Hal F Yee; Jeffrey N Martin; Steven G Deeks; Barbara L Shacklett
Journal:  Blood       Date:  2008-12-23       Impact factor: 22.113

9.  HIV-1 Nef sequence and functional compartmentalization in the gut is not due to differential cytotoxic T lymphocyte selective pressure.

Authors:  Martha J Lewis; Patricia Frohnen; F Javier Ibarrondo; Diane Reed; Varun Iyer; Hwee L Ng; Julie Elliott; Otto O Yang; Peter Anton
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

10.  Differential blood and mucosal immune responses against an HIV-1 vaccine administered via inguinal or deltoid injection.

Authors:  Otto O Yang; F Javier Ibarrondo; Charles Price; Lance E Hultin; Julie Elliott; Patricia M Hultin; Roger Shih; Mary Ann Hausner; Hwee L Ng; Jennifer Hoffman; Beth D Jamieson; Peter A Anton
Journal:  PLoS One       Date:  2014-02-18       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.